CDK11<sup>p110</sup> plays a critical role in the tumorigenicity of esophageal squamous cell carcinoma cells and is a potential drug target
Yue Du(First Affiliated Hospital of Xi'an Jiaotong University), Quancheng Kan(Zhengzhou University), Dan Yan(Jacksonville College), Weiyan Cheng(First Affiliated Hospital of Zhengzhou University), Xin Tian(First Affiliated Hospital of Henan University), Yongliang Yuan(First Affiliated Hospital of Zhengzhou University), Jian Xu(University of California, Los Angeles), Zhiheng Yang(First Affiliated Hospital of Zhengzhou University), Suhua Wang(Changzhou Academy of Intelli-Ag Equipment (China))
Cited by 21
Related Papers
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Superoxide Anion From the Adventitia of the Rat Thoracic Aorta Inactivates Nitric Oxide
|Circulation Research|1998|392
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
|Pharmacology & Therapeutics|2019|245